fda compounding semaglutide enforcement news november 2025 pharmacies to halt sales May 22 The FDA has announced that

WeightCare's approach: Our multivitamin supplement is designed specifically to address the nutritional gaps most common in GLP-1 users, without the excessive dosing that can cause GI discomfort

Common side effects include nausea, diarrhea , vomiting, decreased appetite, and constipation, similar to other GLP-1 medications

Once you identify a reliable supplier, scale to your research needs

Methods Number of Prescriptions and Gross Spending Data: This analysis uses 2019 through 2024 State Drug Utilization Data (SDUD) (downloaded in January 2026)

It accesses doses lower than the usual starter doses on our other GLP-1 programs, as well as additional doses up to 25% of the standard maintenance dose

Portion-controlled muffins, breads and other baked goods formulated with protein isolates offer satisfying options that align with reduced appetite while maintaining nutritional adequacy